239 related articles for article (PubMed ID: 25147230)
1. Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice.
Aqul A; Lopez AM; Posey KS; Taylor AM; Repa JJ; Burns DK; Turley SD
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G836-47. PubMed ID: 25147230
[TBL] [Abstract][Full Text] [Related]
2. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.
Lopez AM; Posey KS; Turley SD
Biochem Biophys Res Commun; 2014 Nov; 454(1):162-6. PubMed ID: 25450374
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease.
Chuang JC; Lopez AM; Posey KS; Turley SD
Biochem Biophys Res Commun; 2014 Jan; 443(3):1073-7. PubMed ID: 24370824
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of the rates of hepatic and intestinal cholesterol synthesis in lysosomal acid lipase-deficient mice before and during treatment with ezetimibe.
Chuang JC; Lopez AM; Turley SD
Biochem Pharmacol; 2017 Jul; 135():116-125. PubMed ID: 28322747
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers of brain cholesterol homeostasis are unchanged despite a smaller brain mass in a mouse model of cholesteryl ester storage disease.
Aqul AA; Ramirez CM; Lopez AM; Burns DK; Repa JJ; Turley SD
Lipids; 2022 Jan; 57(1):3-16. PubMed ID: 34618372
[TBL] [Abstract][Full Text] [Related]
6. PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice.
Lopez AM; Chuang JC; Posey KS; Ohshiro T; Tomoda H; Rudel LL; Turley SD
J Pharmacol Exp Ther; 2015 Nov; 355(2):159-67. PubMed ID: 26283692
[TBL] [Abstract][Full Text] [Related]
7. Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse.
Lopez AM; Chuang JC; Turley SD
Steroids; 2018 Feb; 130():7-14. PubMed ID: 29246491
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific deletion of lysosomal acid lipase leads to cholesteryl ester but not triglyceride or retinyl ester accumulation.
Pajed L; Wagner C; Taschler U; Schreiber R; Kolleritsch S; Fawzy N; Pototschnig I; Schoiswohl G; Pusch LM; Wieser BI; Vesely P; Hoefler G; Eichmann TO; Zimmermann R; Lass A
J Biol Chem; 2019 Jun; 294(23):9118-9133. PubMed ID: 31023823
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span.
Du H; Heur M; Duanmu M; Grabowski GA; Hui DY; Witte DP; Mishra J
J Lipid Res; 2001 Apr; 42(4):489-500. PubMed ID: 11290820
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice.
Du H; Heur M; Witte DP; Ameis D; Grabowski GA
Hum Gene Ther; 2002 Jul; 13(11):1361-72. PubMed ID: 12162818
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific lysosomal acid lipase deficiency protects mice from diet-induced obesity but promotes hepatic inflammation.
Leopold C; Duta-Mare M; Sachdev V; Goeritzer M; Maresch LK; Kolb D; Reicher H; Wagner B; Stojakovic T; Ruelicke T; Haemmerle G; Hoefler G; Sattler W; Kratky D
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Apr; 1864(4):500-511. PubMed ID: 30639734
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
[TBL] [Abstract][Full Text] [Related]
14. Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene.
Pisciotta L; Fresa R; Bellocchio A; Pino E; Guido V; Cantafora A; Di Rocco M; Calandra S; Bertolini S
Mol Genet Metab; 2009 Jun; 97(2):143-8. PubMed ID: 19307143
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lysosomal acid lipase drives the autophagy-lysosomal response and alleviates cholesterol metabolic disorder in ApoE deficient mice.
Li F; Zhao X; Li H; Liu Y; Zhang Y; Huang X; Cao J; Du F; Wu D; Yu H
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Dec; 1866(12):159027. PubMed ID: 34416392
[TBL] [Abstract][Full Text] [Related]
16. Loss of function of lysosomal acid lipase (LAL) profoundly impacts osteoblastogenesis and increases fracture risk in humans.
Helderman RC; Whitney DG; Duta-Mare M; Akhmetshina A; Vujic N; Jayapalan S; Nyman JS; Misra BB; Rosen CJ; Czech MP; Kratky D; Rendina-Ruedy E
Bone; 2021 Jul; 148():115946. PubMed ID: 33838322
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
Tylki-Szymańska A; Jurecka A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):99-106. PubMed ID: 24798600
[TBL] [Abstract][Full Text] [Related]
18. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
Maciejko JJ
Am J Cardiovasc Drugs; 2017 Jun; 17(3):217-231. PubMed ID: 28197978
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
[TBL] [Abstract][Full Text] [Related]
20. LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.
Bowden KL; Dubland JA; Chan T; Xu YH; Grabowski GA; Du H; Francis GA
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1191-1201. PubMed ID: 29599133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
